Societal CDMO Competitors and Similar CompaniesClear all
BTG's competitors and similar companies include Amicus Therapeutics.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ||
Founding Date | Founding Date 1948 | Founding Date 2002 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | |
Employees | Employees 650 | Employees 58415% increase |
Financial | ||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit $561.3m (FY, 2025) |
Net income | Net income £88.3m (FY, 2019) | Net income ($27.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company